Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–20 of 20 trials
Active filters
Clinical trials found
Published and searchable clinical trials
Searching for clinical trials...
- Conditions
- Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
- Locations
-
- Precision Point Specialty LLC PPS Analytics, a Specialty Networks LLC Company Cleveland, Ohio, United States
NCT07451002
- Conditions
- Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
- Locations
-
- Centre Francois Baclesse Caen, France
Recruiting
A Study of Pasritamig (JNJ-78278343) in Combination With Other Agents for Metastatic Prostate Cancer
NCT05818683
- Conditions
- Metastatic Castration-resistant Prostate Neoplasms, Metastatic Hormone-sensitive Prostate Cancer
- Locations
-
- Florida Cancer Specialists Sarasota, Florida, United States
- Start Midwest Grand Rapids, Michigan, United States
- Washington University School Of Medicine St Louis, Missouri, United States
- Perlmutter Cancer Center at NYU Langone Brooklyn Brooklyn, New York, United States
NCT06334120
- Conditions
- Metastatic Hormone-sensitive Prostate Cancer, Non-metastatic Castration-resistant Prostate Cancer
- Locations
-
- Multiple locations Multiple Locations, South Korea
- Conditions
- Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
- Locations
-
- CH Bayonne Bayonne, France
- Institut Bergonié Bordeaux, France
- CHP Brest - Pasteur Brest, France
- Hôpital Henri-Mondor Créteil, France
NCT06991556
- Conditions
- Metastatic Hormone-sensitive Prostate Cancer
- Locations
-
- University of California San Diego - Moores Cancer Center La Jolla, California, United States
- Saint Johns Cancer Institute Santa Monica, California, United States
- Rocky Mountain Cancer Centers Denver, Colorado, United States
- Yale Cancer Center New Haven, Connecticut, United States
Not Yet Recruiting
Evaluation of the Efficacy of Darolutamide Triplet Therapy in Patients With Metastatic Hormone-sensitive Prostate Cancer
NCT07031258
- Conditions
- Darolutamide (DARO) in Combination With Androgen-deprivation Therapy (ADT) and Docetaxel (DOC), Metastatic Hormone-sensitive Prostate Cancer
- Locations
-
Not specified
- Conditions
- Metastatic Hormone-sensitive Prostate Cancer, Parkinson Disease 4, Autosomal Dominant Lewy Body
- Locations
-
- Alaska Clinical Research Center ( Site 0274) Anchorage, Alaska, United States
- Providence Alaska Medical Center ( Site 0276) Anchorage, Alaska, United States
- City of Hope Medical Center ( Site 0217) Duarte, California, United States
- UCLA Hematology/Oncology - Santa Monica ( Site 0241) Los Angeles, California, United States
Completed
PSMA PET/CT-Based Multimodal Model for Predicting Response to First-Line Therapy in mHSPC.
NCT07428642
- Conditions
- Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +9 more
- Locations
-
- The First Affiliated Hospital of Wenzhou Medical University Wenzhou, Zhejiang, China
NCT00309985
- Conditions
- Metastatic Hormone-sensitive Prostate Cancer
- Locations
-
- Providence Cancer Center Anchorage, Alaska, United States
- Fairbanks Cancer Treatment Center at Fairbanks Memorial Hospital Fairbanks, Alaska, United States
- Mayo Clinic Hospital Phoenix, Arizona, United States
- Mayo Clinic Scottsdale Scottsdale, Arizona, United States
NCT02799602
- Conditions
- Metastatic Hormone-sensitive Prostate Cancer
- Locations
-
- Chandler, Arizona, United States
- Tucson, Arizona, United States
- Beverly Hills, California, United States
- Duarte, California, United States
- Conditions
- Metastatic Hormone-sensitive Prostate Cancer, Parkinson Disease 4, Autosomal Dominant Lewy Body
- Locations
-
- Peking University First Hospital ( Site 0800) Beijing, Beijing Municipality, China
- Beijing Cancer Hospital ( Site 0802) Beijing, Beijing Municipality, China
- Chongqing Cancer Hospital ( Site 0815) Chongqing, Chongqing Municipality, China
- The First Affiliated Hospital of Xiamen University (Site 0816) Xiamen, Fujian, China
NCT05381311
- Conditions
- Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +9 more
- Locations
-
- Duke Clinical Research Institute Durham, North Carolina, United States
NCT06452212
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, +7 more
- Locations
-
- KR82001 Seoul, South Korea
NCT06498921
- Conditions
- Metastatic Hormone-sensitive Prostate Cancer
- Locations
-
- Many locations Multiple Locations, Belgium
NCT03532217
- Conditions
- Metastatic Hormone-sensitive Prostate Cancer
- Locations
-
- Washington University School of Medicine St Louis, Missouri, United States
Active, Not Recruiting
An Observational Study to Learn More About Treatment Patterns and Factors Determining the Choice of Treatment in Canadian Men With Metastatic Hormone Sensitive Prostate Cancer in Routine Medical Care
NCT06874114
- Conditions
- Metastatic Hormone-sensitive Prostate Cancer
- Locations
-
- Pentavere Toronto, Ontario, Canada
Active, Not Recruiting
A Study to Learn How Men With Advanced Prostate Cancer Respond to Treatment With Darolutamide and Hormone Therapy, With or Without Chemotherapy, in Real-world Medical Practice
NCT07344779
- Conditions
- Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
- Locations
-
- Many Locations Multiple Locations, Belgium
- Many Locations Multiple Locations, Finland
- Many Locations Multiple Locations, France
- Many Locations Multiple Locations, Germany
Active, Not Recruiting
A Study for the Participants With Metastatic Hormone Sensitive Prostate Cancer (mHSPC) Treated With Androgen Deprivation Therapy (ADT) Plus Apalutamide or Enzalutamide
NCT05901649
- Conditions
- Metastatic Hormone-sensitive Prostate Cancer
- Locations
-
- Akh Wien Vienna, Austria
- Klinikum Wels Grieskirchen Wels, Austria
- Institut Sainte Catherine Avignon, France
- Institut Bergonie Bordeaux, France
NCT05059236
- Conditions
- Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
- Locations
-
- Urology Centers of Alabama, PC - Homewood Homewood, Alabama, United States
- Arizona Urology Specialists - Tucson - W Orange Grove Tucson, Arizona, United States
- Tower Urology Los Angeles, California, United States
- UCI Health Center for Urological Care Orange, California, United States